Pfizer asks US officials to OK promising COVID-19 pill
November 17, 2021
WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.
The company's filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.
Pfizer's pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from...
For access to this article please
sign in or
subscribe.
Reader Comments(0)